A British operative >(Who worked at Bain Capital) was inserted into President Trump’s White House in an effort to tarnish President Trump’s image and then derail the 2020 Election audit efforts.
We’ve previously reported that an individual named Don Berlin inserted a document into President Trump’s inner circle days before Jan 6 in an effort to set President Trump up for perceived insurrection. A summary of this document was then scooped up by the Jan 6 committee and shared with multiple media outlets in an attempt to claim he attempted an insurrection after the 2020 Election steal.
We now know that Berlin wasn’t alone. Another individual, Andrew Whitney, with connections to British Intelligence, also wormed his way into President Trump’s inner circle in an effort to tarnish President Trump and then derail the post-2020 Election audit efforts.
Andrew Whitney claimed in one resume where he is listed on the Board of Phoenix Biotechnology, Inc., that he formerly worked for Bain and Co consulting and more.
When looking at all three resumes for Andrew Whitney, we know the following:
- All three bios are consistent about Whitney’s experience at Bain & Co, and Bain Leveraged, His buyout practice, and the claim to be a postgraduate at Cambridge.
- The earliest of these three bios appears to be the Andrew Whitney – Future in Review, where it is indicated that he has 16 years of experience as an entrepreneur.
- In the Cimarron bio, his claim to have worked as a “market maker” on the London Stock Exchange, while employed by the FTSE energy stock in 1989, appears questionable, in that he would have been only 18 or 19 years old at that time.
- The Cimarron bio is also the only place where he states he wrote Masters and PhD dissertations. A search of www.researchgate.net revealed a number of articles that Whitney collaborated on at Cambridge, but no document was located that was specifically titled to address the post-Soviet Russian energy sector.
- The Phoenix Biotechnology bio states that he has 25 years of experience in the licensing and management of IP rights. There is no specific mention of that in the previous two bios.
Whitney used these resumes as a means to worm himself into President Trump’s orbit. He was introduced to President Trump and attempted to push an untested solution for COVID-19 in the summer of 2020. Per a hit piece in the Washington Post in August 2020, Andrew Whitney met with President Trump in the White House pushing a remedy for COVID-19 that no one previously heard of. WaPo writes:
Trump has solicited advice on the virus from a medley of voices, with anyone gaining access to him able to bend his ear about possible treatments. The chorus includes Fox News commentator Laura Ingraham, who has paid regular visits to the Oval Office to discuss hydroxychloroquine, the anti-malarial drug that Trump promoted as a cure for the coronavirus despite scientific studies showing that the drug if used as a treatment could have deadly side effects.
The president recently hosted Andrew Whitney, a biopharmaceuticals executive on the board of a company called Phoenix, who met in the Oval Office with Trump. Whitney, who has a limited health background, pitched Trump on a botanical extract called oleandrin as a treatment for the coronavirus, according to two senior administration officials with knowledge of the discussion.
There are numerous businesses identified when performing a search of businesses connected to Andrew Whitney. One business among many connected to Whitney is Rook Perspectives, LLC. This company is connected to Whitney’s brother, Mark Andrew Whitney (dressed in his military uniform below).
A British operative >(Who worked at Bain Capital) was inserted into President Trump’s White House in an effort to tarnish President Trump’s image and then derail the 2020 Election audit efforts.
We’ve previously reported that an individual named Don Berlin inserted a document into President Trump’s inner circle days before Jan 6 in an effort to set President Trump up for perceived insurrection. A summary of this document was then scooped up by the Jan 6 committee and shared with multiple media outlets in an attempt to claim he attempted an insurrection after the 2020 Election steal.
We now know that Berlin wasn’t alone. Another individual, Andrew Whitney, with connections to British Intelligence, also wormed his way into President Trump’s inner circle in an effort to tarnish President Trump and then derail the post-2020 Election audit efforts.
Andrew Whitney claimed in one resume where he is listed on the Board of Phoenix Biotechnology, Inc., that he formerly worked for Bain and Co consulting and more.
When looking at all three resumes for Andrew Whitney, we know the following:
1. All three bios are consistent about Whitney’s experience at Bain & Co, and Bain Leveraged, His buyout practice, and the claim to be a postgraduate at Cambridge.
2. The earliest of these three bios appears to be the Andrew Whitney – Future in Review, where it is indicated that he has 16 years of experience as an entrepreneur.
3. In the Cimarron bio, his claim to have worked as a “market maker” on the London Stock Exchange, while employed by the FTSE energy stock in 1989, appears questionable, in that he would have been only 18 or 19 years old at that time.
4. The Cimarron bio is also the only place where he states he wrote Masters and PhD dissertations. A search of www.researchgate.net revealed a number of articles that Whitney collaborated on at Cambridge, but no document was located that was specifically titled to address the post-Soviet Russian energy sector.
5. The Phoenix Biotechnology bio states that he has 25 years of experience in the licensing and management of IP rights. There is no specific mention of that in the previous two bios.
Whitney used these resumes as a means to worm himself into President Trump’s orbit. He was introduced to President Trump and attempted to push an untested solution for COVID-19 in the summer of 2020. Per a hit piece in the Washington Post in August 2020, Andrew Whitney met with President Trump in the White House pushing a remedy for COVID-19 that no one previously heard of. WaPo writes:
Trump has solicited advice on the virus from a medley of voices, with anyone gaining access to him able to bend his ear about possible treatments. The chorus includes Fox News commentator Laura Ingraham, who has paid regular visits to the Oval Office to discuss hydroxychloroquine, the anti-malarial drug that Trump promoted as a cure for the coronavirus despite scientific studies showing that the drug if used as a treatment could have deadly side effects.
The president recently hosted Andrew Whitney, a biopharmaceuticals executive on the board of a company called Phoenix, who met in the Oval Office with Trump. Whitney, who has a limited health background, pitched Trump on a botanical extract called oleandrin as a treatment for the coronavirus, according to two senior administration officials with knowledge of the discussion.
There are numerous businesses identified when performing a search of businesses connected to Andrew Whitney. One business among many connected to Whitney is Rook Perspectives, LLC. This company is connected to Whitney’s brother, Mark Andrew Whitney (dressed in his military uniform below).
(post is archived)